click & collect
Collect your order in-store R35 or FREE for orders over R200.
.
GrippeFlu Cough and Cold Syrup 100ml is recommended for the relief of symptoms associated with colds and flu. This cough and cold syrup is formulated with ivy leaf extract, vitamin C and pelargonium, and is alcohol and sugar free.
In Stock
Store pick-up
Collect your order in-store R35 or FREE for orders over R200.
Standard Delivery
Door-to-door courier countrywide R80 or FREE for orders over R600.
See if we have this item in your closest store
Delivered in 2 - 4 working days.
Description:
Astral Pharma GrippeFlu Cough & Cold Syrup 100 ml
Detailed Description:
S0 Category of medicine: D.
Class: D5.8 preparations for the common cold including nasal decongestants. Complementary medicine. Western herbal combination.
Cough relieving.
Mucolytic.
Expectorant.
Spasmolytic.
Composition:
Each 5 ml contains:
Hedera helix (ivy leaf) extract (4-8:1) - 35 mg.
Vitamin C (ascorbic acid) - 100 mg.
Pelargonium PS70 (pelargonium sidoides DC. (pelargonium root extract) - 56 mg.
Preserved with:
Potassium sorbate - 0,035% (m/v).
Sodium benzoate - 0,045% (m/v).
Contains sorbitol - 46,179% (m/v).
Pack size:
100 ml
Quantity in pack:
1
Marketing description:
Berry/menthol flavour.
S0.
GrippeFlu.
Cough and cold syrup.
With ivy leaf extract, vitamin C & pelargonium.
Alcohol & sugar free.
Cough syrup.
For the whole family.
For the relief of symptoms associated with colds and flu.
100 ml.
Astral Pharma.
Brand:
GrippeFlu
Package type:
Box
Usage instructions:
Dosage and directions for use:
Adults: 5 ml three times daily.
Adolescents above 13 years: 5 ml three times daily.
Children ages 6-12 years: 5 ml two times daily.
Shake well before use.
Storage instructions:
Store at or below 25 degrees C in a dry place.
Keep the bottle tightly closed. Protect from light.
Warnings:
Keep out of reach of children.
Warnings and special precautions:
Contains sorbitol and may have a laxative effect.
May cause hypersensitivity or gastrointestinal reactions as well as hepatotoxicity and the development of hepatitis.
This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use.